Level Bio AB (publ) (NGM:LEVBIO)
Sweden
· Delayed Price · Currency is SEK 0.3620
+0.0380 (11.73%)
At close: Dec 3, 2025
Level Bio AB Revenue
Level Bio AB had revenue of 6.75M SEK in the quarter ending September 30, 2025, with 5.14% growth. This brings the company's revenue in the last twelve months to 30.39M, up 27.99% year-over-year. In the year 2024, Level Bio AB had annual revenue of 25.10M, down -3.83%.
Revenue (ttm)
30.39M
Revenue Growth
+27.99%
P/S Ratio
0.72
Revenue / Employee
3.04M
Employees
11
Market Cap
21.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.10M | -999.39K | -3.83% |
| Dec 31, 2023 | 26.10M | -8.24M | -23.99% |
| Dec 31, 2022 | 34.33M | -9.63M | -21.91% |
| Dec 31, 2021 | 43.96M | 20.43M | 86.86% |
| Dec 31, 2020 | 23.53M | 6.45M | 37.77% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Investor AB | 133.31B |
| Atlas Copco AB | 171.55B |
| AB Volvo | 493.79B |
| ASSA ABLOY AB | 153.68B |
| EQT AB | 30.08B |
| Skandinaviska Enskilda Banken AB | 76.49B |
| Sandvik AB | 120.37B |
| Swedbank AB | 70.81B |